PARIS – The public-private university hospital consortium Dhune, from the Provence-Alpes-Côte d'Azur (PACA) region, reported the creation of a seed capital fund dedicated exclusively to life sciences, amounting to $112 million. "First [is] the [inaugural] specialized seed fund for a French region dedicated primarily to startups in the field of neurodegenerative disease, as well as health care," Olivier Blin, head of the clinical pharmacology and pharmacovigilance department at Marseille University Hospital, told BioWorld.